SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #557CAS 1区Top JournalHybrid

Cancer Immunology Research

Abbreviation (ISO):CANCER IMMUNOL RES
Country: United States•WoS SCIE Quartile: Q1•Scopus SJR: 3.48•SCImago Rank: #557•Identifier (ISSN):2326-6066(Print)/2326-6074(Online)•Articles / Year: 111•Estimated Publication Fee (APC): $4,219 USD
Clarivate IF (2026)Q1
7.9
↓ -0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
62

62 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
111articles/year
32.68% Gold OA•93.52% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 7.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.9)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.2)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.1)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.1)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 12.02)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.151)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.728)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.619)
🔵 Computed
20183.00đ
WoS Q1 có IF ≥ 5.0(IF: 9.188)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

Topics Covered (Recognized by AI)
Medicine95.3%Biology94.6%Genetics93.8%Immunology91.2%Internal medicine89.8%Immune system87%Cancer82.3%Chemistry79.3%Cancer research79.1%Biochemistry78.2%Immunotherapy68.5%Antigen52%In vitro44.4%Cytotoxic T cell38.1%T cell37.9%CD834.8%Gene33.5%Cancer immunotherapy33.4%Receptor29.8%Tumor cells27.5%Pathology26.2%Tumor microenvironment24.7%Antibody23.7%Cell biology23.6%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #557Scopus Q1SCImago Profile
Scopus Coverage:2013-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology
Scopus Citation Rank (SJR)Q1
3.48

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
157

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
6.65

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,219 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations2,946
3-Year Documents386
Citable Documents371

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
ImmunologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Periodic
Editorial Address
615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
IMMUNOLOGY
JCRSCIE
22/183Q1
ONCOLOGY
JCRSCIE
45/333Q1
IMMUNOLOGY
JCISCIE
16/183Q1
ONCOLOGY
JCISCIE
33/333Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—36696
20258.2451805
20248.12711,750
202310.12342,570
202212.023634,607
202111.1512345,626
20208.7285799,879
20198.61964016,884
20189.18830814,053
2017—27713,532
2016—77213,015
2015—31216,490
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cancer Immunology Research

WoS Q1
581114201820192020202120222023202420258.20
Annual Impact Factor Metric
2025:8.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c0bd95c0-60f0-40c8-a2c0-4c422728af87
Database Updated: 2026-10-01